Abstract-Hypertension and inflammation during pregnancy are suggested to contribute to the development of postpartum depression and anxiety. Using a rat model of severe preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome, which displays both hypertension and inflammation during pregnancy, we evaluated whether rats were prone to develop depression or anxiety in the postpartum period. On gestational day 12, miniosmotic pumps infusing sFlt-1 (soluble fms-like tyrosine kinase-1) and sEng (soluble endoglin) were placed into rats, a subset of these rats was infused with 2 mg/kg of Orencia (abatacept) the following day to determine whether immune suppression via T-cell depletion prevented any changes in maternal depression or anxiety-like behavior. All rats, including normal pregnant (NP) controls, delivered between gestational days 21 and 22. Postpartum severe preeclamptic rats buried significantly more marbles compared with NP rats (P=0.002) and Orencia-treated rats (P=0.05). Severe preeclamptic rats spent significantly more time in closed arms of the elevated plus maze compared with NP rats (P=0.009) and Orencia-treated rats (P=0.05). Severe preeclamptic rats were hypertensive compared with NP (P=0.03) and Orencia-treated rats (P=0.01). Finally, severe preeclamptic rats had increased blood-brain barrier permeability compared with NP rats (P=0.03), which was reversed in Orencia-treated rats (P=0.008). These results suggest that severe preeclampsia/hemolysis, elevated liver enzymes, and low platelet count syndrome during pregnancy contributes to an increase in anxiety-like behavior, blood-brain barrier permeability, and hypertension in the postpartum. The current results suggest that T-cell suppression during pregnancy can also help prevent chronic hypertension and increased anxiety in the postpartum period. (Hypertension. 2018;72:946-954.
H ypertension affects 3% to 10% of pregnant women, which is most commonly presented as either preeclampsia or hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome.
1,2 HELLP occurs in 10% to 20% of women with preeclampsia and in 0.5% of women without preeclampsia. 3 There is increasing evidence demonstrating that women who suffered severe preeclampsia or HELLP are at an increased risk for the development of postpartum depression, anxiety, post-traumatic stress disorder (PTSD) and cognitive impairments later in life. [4] [5] [6] There is an increased risk for depression during the perinatal period in which 10% to 43% of pregnant women have been found to meet the criteria for depression. 7, 8 Five percent to 20% of women are also affected by postpartum anxiety or increased levels of stress that is often linked to depression. 9, 10 The pathogenesis of depression and anxiety is unknown and is likely to vary among individuals; however, obstetric complications, such as preeclampsia/HELLP, along with activation of the immune system have been linked to depression and anxiety in the postpartum period. 11, 12 Although roles for inflammation, T cells, and inflammatory cytokines have been suggested as contributors to hypertension, 13, 14 preeclampsia, HELLP, 15, 16 and mood disorders, 12, 17 the studies examining this relationship are scarce. In the current study, we use an animal model of severe preeclampsia (sPE)/HELLP to examine the relationship between inflammation and compromised blood-brain barrier (BBB) permeability during pregnancy and the advent of depressive and anxiety-like behavior in the postpartum period. To assess depressive-like behavior, or anhedonia, in rodents, we used the 2-bottle sucrose preference test, 18 and for anxiety-like behavior, we used marble burying, 19 elevated plus maze, 20 and novelty-suppressed feeding. 21 We have previously reported that 2 mg/kg of Orencia (abatacept-a fusion protein that binds to the extracellular domain of cytotoxic T-lymphocyte-associated protein 4, which inhibits the costimulation needed for T-cell activation) infused on gestational day (GD)13 of pregnancy attenuates hypertension, the increase in T Cells, systemic inflammation, and BBB permeability in pregnant HELLP rats. 22 Because all of these factors also influence depression and anxiety, we also tested the hypothesis that decreasing hypertension, inflammation, and BBB permeability during pregnancy, via attenuation of systemic T-cell activation, 22 prevents any adverse behaviors in the postpartum period.
Methods
The authors declare that all supporting data are available within the article and in the online-only Data Supplement; detailed data are available from the corresponding author on reasonable request.
All studies were performed in Sprague-Dawley female rats (Harlan, Indianapolis, IN). Animals were housed in a temperaturecontrolled room with a 12:12 reverse light:dark cycle. All experimental procedures used in this study were in accordance with the National Institutes of Health guidelines for use and care of animals and approved by the Institutional Animal Care and Use Committee at the University of Mississippi Medical Center.
Induction of sPE/HELLP
To induce sPE/HELLP, on GD12, normal pregnant (NP; n=32) rats were infused with of sFlt-1 (soluble fms-like tyrosine kinase-1) and sEng (soluble endoglin; 4.7 and 7 µg/kg, respectively; R&D Systems, Minneapolis, MN) as described previously.
22-24 Because we are not able to differentiate between sPE and HELLP during pregnancy in the current study, all rats infused with sFlt-1 and sEng are grouped as sPE/HELLP (online-only Data Supplement). On GD13, a subset of rats infused with sFlt-1 and sEng (n=16) was infused with Orencia (2 mg/kg) via the jugular vein. 22 Rats not infused with sFlt-1 or sEng served as NP controls (n=16). Dams gave birth on GD21-22, which was counted as postpartum day 0 (Figure 1 ). Twelve to 24 hours after birth, miniosmotic pumps were removed, and all delivered pups were removed. After recovering from surgery, dams were group housed for the remainder of the study.
Behavioral Protocols
Motor activity, anxiety, and anhedonia were assessed with a series of well-established behavioral tests between postpartum weeks 2 and 4. All animals were submitted to behavioral testing under lowintensity lighting during the animal's active cycle either in the Animal Behavioral Core or within the Center for Comparative Research.
Motor function was assessed by the total distance traveled and resting time in a novel environment. Postpartum rats were subjected to the marble burying because a high number of covered marbles is an indicator of anxiety, 19 the elevated plus maze, a pharmacologically validated test used to assess anxiety in rodents, 20 and novelty-suppressed feeding (measures of anxiety and depression-like behaviors in rats). 21 Sucrose preference-a reward-based test built on the rodent's natural interest in sweet foods/solutions-was measured to determine anhedonia in postpartum rats (online-only Data Supplement).
Hypertension, Inflammation, and Flow Cytometry Assays

Mean Arterial Pressure
Mean arterial pressure was determined as previously described utilizing indwelling carotid catheters 23, 25, 26 (online-only Data Supplement). Immediately after mean arterial pressure measurement, whole blood was collected to assess lactate dehydrogenase (hemolysis), aspartate aminotransferase (liver enzymes), and platelet counts. 23, 24 Whole blood, liver, spleens, and kidneys were collected for flow cytometry and ELISA experiments (online-only Data Supplement). Unless animals were being assessed for BBB permeability or flow cytometry, brains were dissected into frontal cortex, posterior cortex, cerebellum, and brain stem sections; snap-frozen; and stored at −80°C for future studies.
Assessment of BBB Permeability
To evaluate Evans blue extravasation into the brain and maternal organs, rats (n=5 per group) were infused with Evans Blue (MP Biomedical, Santa Ana, CA) as described previously 22 (online-only Data Supplement).
Statistical Analysis
All data are expressed as a mean+SEM when applicable. Differences between groups were analyzed via a 1-way ANOVA with Tukey multiple comparisons test or Student t test for post hoc analysis using GraphPad Prism 7.02. Data were considered statistically significant at P values <0.05. All reported P values are the results from post hoc analysis conducted after the discovery of significant main effects in the ANOVA unless stated otherwise.
Results
Immune Suppression During Pregnancy Prevents Anxiety-Like Behavior and Anhedonia in Postpartum sPE/HELLP Rats
There was a significant increase in the distance traveled among sPE/HELLP rats compared with NP rats (P=0.01; Figure 2A ), which was prevented in sPE/HELLP+Orencia rats (P=0.02). This was accompanied by a subsequent decrease in resting time in sPE/HELLP rats (P=0.007; Figure 2B ).
Compared with sPE/HELLP dams, both NP (P=0.002) and sPE/HELLP+Orencia (P=0.05) dams buried significantly less marbles ( Figure 2C ). In the elevated plus maze sPE/HELLP rats spent significantly less time in open arms (P=0.04) compared with NP rats, which was not significantly affected in sPE/ HELLP+Orencia rats (P=0.28; Figure 2D ). sPE/HELLP rats spent significantly more time in the closed arms compared with NP rats (P=0.009), which was reversed in sPE/HELLP+Orencia rats (P=0.05; Figure 2D ). There were no statistically significant differences between the 3 groups in the latency to feed in noveltysuppressed feeding when assessed by 1-way ANOVA (P=0.58). However, when the time taken to initially approach the food was assessed, sPE/HELLP rats took significantly longer to approach the food compared with NP rats (P=0.02; Figure 2E ). sPE/HELLP rats did not display a significant decrease in anhedonia compared with NP rats (P=0.12); however, sPE/ HELLP+Orencia rats drank significantly more sucrose water than untreated sPE/HELLP rats (P=0.03; Figure 2F ).
Immune Suppression During Pregnancy Prevents Postpartum Hypertension in sPE/HELLP Rats
Six weeks postpartum, rats with a history of sPE/HELLP were hypertensive compared with NP rats (P=0.03; Figure 3A ). sPE/HELLP+Orencia rats were not hypertensive in the postpartum period compared with untreated sPE/HELLP rats (P=0.01; Figure 3A ). There was no significant difference in hemolysis between NP and sPE/HELLP rats (P=0.63); however, sPE/HELLP+Orencia rats had significantly less hemolysis than sPE/HELLP rats (P=0.03; Figure 3B ). Liver enzymes were significantly increased in sPE/HELLP rats compared with NP rats (P=0.03). sPE/HELLP+Orencia rats had significantly less liver enzymes compared with both NP (P=0.003) and sPE/HELLP rats (P=0.002; Figure 3C ). There were no significant differences in platelets between the groups (P=0.26; Figure 3D ). sPE/HELLP rats delivered significantly earlier than NP rats (P=0.04) and sPE/HELLP+Orencia rats (P=0.003). There was not a statistically significant difference in litter sizes between the groups (P=0.14) or in organs with the exception of the spleen (online-only Data Supplement).
sFlt-1 and sEng Levels Subside in the Postpartum Period
There were no significant differences in circulating levels of sFlt-1 between NP and sPE/HELLP rats when measured via Student t test (P=0.44; Figure 4A ). Circulating levels of sFlt-1 were below levels of detection in sPE/HELLP+Orencia rats. There were no significant differences in circulating levels of sEng (P=0.89; Figure 4B ). There was no significant difference in circulating levels of TNF-α (tumor necrosis factor-α; P=0.88) between the NP and sPE/HELLP rats ( Figure 4C ). However, TNF-α levels were significantly decreased in sPE/ HELLP+Orencia rats compared with NP (P=0.006) and sPE/ HELLP rats (P=0.001). Circulating IL (interleukin)-17 was not detectable via ELISA in any of the 3 groups of postpartum rats.
CD4 and CD8 T Cells Are Suppressed in sPE/HELLP+Orencia Rats
There was not a significant difference in circulating CD (cluster of differentiation) 4 + T cells between NP and sPE/ HELLP rats (P=0.57); however, sPE/HELLP+Orencia rats had significantly decreased CD4 + T compared with NP (P=0.02) and sPE/HELLP rats (P=0.03; Figure 5A ). sPE/HELLP rats Postpartum severe preeclampsia (sPE)/hemolysis, elevated liver enzymes, and low platelet count (HELLP) rats have evidence of hyperactivity and anxiety-like behavior. sPE/HELLP rats had a significant increase in distance traveled (A) and a significant decrease in resting time (B) compared with postpartum normal pregnant (NP) rats when assessed in the open field. Covered marbles were counted to assess anxiety, and sPE/HELLP rats buried significantly more marbles compared with NP and Orencia-treated rats (C). sPE/HELLP rats also displayed anxiety-like features indicated by decreased time spent in open arms and increased time spent in closed arms of the elevated plus maze compared with both NP and sPE/HELLP+Orencia rats (D). sPE/HELLP rats had a statistically significant increased latency to approach the food in novelty-suppressed feeding compared with postpartum NP rats (E). sPE/HELLP rats tended to consume less sucrose water compared with NP rats; however, sPE/HELLP+Orenica rats drank significantly more sucrose water compared with untreated sPE/HELLP rats (F). ≠P<0.05, ≠≠P<0.005 between NP and sPE/HELLP; *P<0.05 between sPE/HELLP and sPE/HELLP+Orencia rats. n=16 rats per group.
had a significant increase in splenic CD4 + T cells compared with NP rats (P=0.0006), which was significantly decreased in sPE/HELLP+Orencia rats (P=0.0004; Figure 5A ). In the kidney, sPE/HELLP rats had significantly more CD4 + T cells compared with NP rats (P=0.0003), which was reduced in sPE/HELLP+Orencia rats (P=0.0001; Figure 5A ). There were no statistically significant differences in CD4 + T cells in the liver between the groups (P=0.31; Figure 5A ).
Circulating CD8 + T cells were not significantly different between the groups of rats (P=0.26); however, splenic CD8 + T cells were significantly increased in sPE/HELLP compared with NP rats (P=0.04; Figure 5B ). sPE/HELLP+Orencia rats had significantly decreased CD8 + T cells in the compared with NP (P=0.04) and sPE/HELLP rats (P=0.0001; Figure 5B ). sPE/HELLP rats had a significant increase in kidney CD8 + T cells compared with NP rats (P=0.04), which was reduced in sPE/HELLP+Orencia rats (P=0.05; Figure 5B ).There were no statistically significant differences in CD8 + T cells in the liver between the 3 groups (P=0.95; Figure 5B ).
BBB Damage Persists Into the Postpartum Period
Similar to what occurs during pregnancy, there were no statistically significant changes in BBB permeability in the frontal cortex of postpartum sPE/HELLP rats compared with NP rats regardless of Orencia administration (P=0.537; Figure 6 ). BBB permeability was significantly increased in the posterior cortex of sPE/HELLP rats compared with NP rats (P=0.03; Figure 6 ) but not sPE/HELLP+Orencia rats (P=0.91). In the brain stem/ cerebellum region, sPE/HELLP rats had significantly more BBB permeability compared with NP rats (P=0.03; Figure 6 ), which was significantly reduced with Orencia treatment (P=0.008). Orencia infusion decreases circulating sFlt-1 (soluble fms-like tyrosine kinase-1) and TNF-α (tumor necrosis factor-α) levels in postpartum severe preeclampsia (sPE)/hemolysis, elevated liver enzymes, and low platelet count (HELLP) rats. There were no significant changes in circulating levels of sEng (A), sFlt-1 (B), or TNF-α (C) between postpartum normal pregnant (NP) and sPE/ HELLP rats when measured via ELISA, whereas sFlt-1 was undetectable in sPE/HELLP rats infused with Orencia. Orencia infusion did not affect circulating sEng levels and significantly decreased TNF-α levels compared with both NP and sPE/HELLP rats. **P<0.005 between indicated groups. n=8 in NP and sPE/HELLP rats; n=6 in sPE/HELLP+Orencia. Flt-1 indicates fms-like tyrosine kinase-1. T-cell suppression during pregnancy prevents severe preeclampsia (sPE)/ hemolysis, elevated liver enzymes, and low platelet count (HELLP)-induced hypertension in the postpartum period. sPE/HELLP rats have significantly increased mean arterial pressure (MAP; A) but not hemolysis (B) in the postpartum period compared with normal pregnant (NP) and sPE/HELLP+Orencia rats. Postpartum sPE/HELLP rats have significantly increased liver enzymes (C) compared with both postpartum NP and sPE/HELLP+Orencia rats; however, there were no statistically significant changes in platelet levels between the groups (D). ≠P<0.05 between NP and sPE/ HELLP; *P<0.05, **P<0.005 between sPE/ HELLP and sPE/HELLP+Orencia rats; aP<0.05 between NP and sPE/HELLP+Orencia rats. n=16 per group for MAP; n=11 per group/ biochemical measurements.
There were no statistically significant differences in permeability in the liver (P=0.37), spleen (P=0.99), or kidney (P=0.18) when measured by 1-way ANOVA (online-only Data Supplement).
Discussion
It is well documented that women with a history of highrisk pregnancies have an increased risk of developing cardiovascular and cerebrovascular disease later in life. 27, 28 More recently, an increased risk in cognitive and mental disorders has been identified. [29] [30] [31] [32] In the current study, we modeled sPE/ HELLP syndrome by chronically infusing sFlt-1 and sEng into pregnant rats beginning on GD12. The imbalance in sFlt-1 and sEng is similar to what is seen in women with sPE/HELLP syndrome 33 and induces sPE/HELLP syndrome in pregnant rats. 22, 23, 34 We have previously reported that infusion of sFlt-1 and sEng into pregnant rats resulted in hypertension, increased CD4 + and CD8 + T cells, had no significant effect on B-cell populations, and increased inflammatory cytokines and BBB disruption by GD19 of pregnancy. 22 Furthermore, infusion of Orencia to HELLP rats attenuated all of the above factors. In the current study, we sought to determine whether infusion of sFlt-1 and sEng during pregnancy resulted in chronic hypertension, inflammation, and BBB disruption in postpartum rats once the source of sFlt-1 and sEng had been removed. We also wanted to determine whether a single infusion of Orencia during midpregnancy had any long-lasting effects into the postpartum period and finally whether this experimental model of sPE/HELLP was associated with changes in anhedonia and anxiety in the postpartum period. In the current study, postpartum rats with a history of sPE/HELLP had evidence of hyperactivity and increased anxiety compared with NP rats. Importantly, these changes in behavior were associated with hypertension, increased splenic and renal T cells, and increased BBB permeability to Evans blue dye. However, there were no changes in sFlt-1, sEng, or TNF-α levels between postpartum sPE/HELLP and NP rats, suggesting that the behavioral changes and persistent hypertension may not be a result of current systemic inflammatory processes.
Several studies have identified positive associations between preeclampsia and HELLP during pregnancy and the development of postpartum depression, anxiety, or PTSD. [35] [36] [37] [38] In the current study, we demonstrated that rats with a history of sPE/HELLP had increased anxiety relative to rats with a normal pregnancy and sPE/HELLP rats infused with Orencia. These results are confirmed by clinical studies, which have reported that women with preeclampsia or HELLP have increases in PTSD. 5, 39 As to be expected, PTSD after pregnancy has been associated with traumatic birth events and infant morbidity and mortality. 40 To compensate for pup morbidity/mortality problems, all pups were removed from dams within 24 hours of delivery. There was not a significant decrease in anhedonia in rats because of sPE/HELLP when measured via the 2-bottle sucrose test; however, sPE/HELLP rats treated with Orencia during pregnancy did have a greater preference for sucrose compared with untreated sPE/HELLP rats. Motor activity, assessed by total distance traveled and movement time, was positively associated with increased anxiety behavior in sPE/HELLP rats. As with the anxiety-like behaviors, Orencia infusion during pregnancy to sPE/HELLP rats prevented the alterations in behavior.
Although we only used marble burying, elevated plus maze, and novelty-suppressed feeding to assess changes in anxiety in the current study, futures studies examining behaviors specific to PTSD and studies assessing mother-pup interaction will need to be conducted. We also cannot overlook the importance of other biological factors, such as the hypothalamic-pituitary-adrenal, axis which plays an important role in contributing to anxiety and depression. 41 Interestingly, diurnal salivary cortisol excretion was not found to be increased in women with either preeclampsia or HELLP compared with NP women when tested during pregnancy, 42 indicating that changes in maternal stress hormones may not be detectable until late pregnancy of after delivery.
There was not a significant change in circulating sEng, sFlt-1, or TNF-α between NP and sPE/HELLP postpartum rats, and IL-17 was not detectable via ELISA in the circulation. These findings are consistent with those reported by others who also did not find evidence of a continued immune response in the postpartum period after preeclampsia when assessed via ELISA. 43, 44 Rats treated with Orencia had littleto-no detection of TNF-α and sFlt-1 compared with NP and sPE/HELLP rats, whereas sEng levels were not affected by Orencia treatment suggesting that perhaps sEng is not regulated by T cells by maybe by a different immune pathway. When we examined the levels of CD4 and CD8 T cells, they were similar to our ELISA results in that there were not any significant changes in circulating T cells between postpartum NP and sPE/HELLP. However, both the spleen and the kidney had significantly increased levels of T cells relative to NP rats.
We have previously reported that Orencia infused during pregnancy attenuates hypertension, the increase in T cells, systemic inflammation, and BBB permeability in pregnant HELLP rats. 22 We were surprised to see that this single infusion of Orencia during pregnancy not only affected the behavioral changes in postpartum rats with sPE/ HELLP but also significantly decreased T cells in select organs compared with sPE/HELLP rats. The lack of residual antiangiogenic imbalance in this model was unexpected but is similar to what is seen in the more mild model of placental ischemia induced via a reduction in uteroplacental perfusion. 43 The studies examining the chronic effects of Orencia are few, but both experimental and clinical studies have found that Orencia treatment prevents chronic disease progression and immune cell suppression when it was administered at multiple time points. [45] [46] [47] During pregnancy, Orencia infusion into NP rats was not found to have a statistically significant effect on hypertension, inflammation, or BBB permeability. So we did not include this group of rats for postpartum examination. 22, 48 However, future studies will need to examine the effects of T-cell suppression during pregnancy in NP rats to determine whether there are any behavioral or immune changes because of Orencia alone. sPE/HELLP rats had a significant increase in BBB permeability in the posterior cortex and in the brain stem/cerebellum compared with NP rats, which was not protected by Orencia in the case of the posterior cortex. We have also previously reported that during pregnancy, rats with HELLP did not have a significant increase in BBB permeability in the frontal cortex, 22 which is similar to what is currently reported. This is consistent with a recent study by Clayton et al 49 that reported a reduction in the tight-junction occludin expression in the posterior cerebrum of postpartum placental ischemic rats, indicative of BBB damage. Damage to the posterior region of the brain in postpartum rats is also supported by clinical studies indicating brain damage in the subcortical organs of women with a history of preeclampsia and HELLP. 31, 50 In general, the posterior regions of the brain have been reported to have increased white matter damage in women in a history of preeclampsia. 31, 50 We did not assess white matter damage in the current study but will plan to examine not only white matter but also cognitive function.
It is possible that the chronic increase in blood pressure that we see in postpartum sPE/HELLP rats could also contribute to long-lasting changes in BBB permeability. Even though some women with sPE/HELLP during pregnancy have a resolution in hypertension before hospital discharge, between 41% and 57% of women still experience hypertension in the postpartum period even while taking antihypertensives. 51, 52 It is also important to note that in the clinical setting, women are often treated with antihypertensives and magnesium sulfate to decrease hypertension and offer neuroprotection. 53 This was not the case in untreated rats with sPE/HELLP, which may be one reason for the continued hypertension. Our current results differ from previous postpartum studies of animal models of placental ischemia, which do not have significant increases in mean arterial pressure relative to postpartum NP rats. 43, 49, 54 It is important to note that in these previous studies, placental ischemia during pregnancy was induced through either a mechanical reduction of uteroplacental blood flow or via lipopolysaccharide administration, which does not create sPE or HELLP in rats. 34, 55, 56 This difference in the severity of disease pathology might be one explanation for the difference in hypertension during the postpartum period, despite the similarities in postpartum inflammation.
Hypertension and inflammation during pregnancy, such as that seen in sPE/HELLP, is associated with increased BBB permeability, impairments in cerebral blood flow autoregulation, cerebral edema, and neuroinflammation. [57] [58] [59] [60] [61] Although the exact mechanism(s) responsible for the CNS complications associated with sPE/HELLP are not known, it is believed that the cerebral circulation is involved. It is well established in both human and animal studies that circulating factors, in subjects with preeclampsia or HELLP, contribute to BBB disruption and neuroinflammation. 22, 57, 60, 62 Therefore, one could postulate that the increase in BBB permeability or decrease in BBB function could contribute to changes in the neural environment during pregnancy or the postpartum period leading to behavioral changes.
63,64
Although we did not directly test this theory in the current study, we do think that the postpartum behavioral changes that are present in the current model are due, at least in part, to neuroinflammatory mechanisms associated with the increase in BBB disruption.
Perspectives
Cerebral complications associated with sPE/HELLP contribute significantly to maternal morbidity and mortality both during pregnancy and in postpartum periods. Hypertension and BBB disruption during pregnancy, mediated partly by systemic inflammation and neuroinflammation, may play an important role in the underlying pathophysiology of the varying CNS complications and ensuing postpartum behavioral modifications associated with sPE/HELLP. In the current study, for the first time to our knowledge, a relationship between hypertension and increased BBB permeability during pregnancy with hypertension and negative behavioral outcomes in the postpartum period in an animal model has been demonstrated. Inactivation of T cells may serve as a potential therapy for the treatment of sPE/HELLP, which may lead to improvement in overall maternal and fetal morbidity and mortality. To further understand the underlying mechanism of CNS complications associated with sPE/HELLP, the role of specific T helper cells and evaluation of neuroinflammation need to be further studied. 
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